Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response

BACKGROUND: Pegylated (PEG)-interferon (IFN)-alfa-2a plus ribavirin (RBV) therapy for 24 weeks is now a standard treatment protocol for patients with hepatitis C virus (HCV) genotype 2. As RBV cannot be used in certain situations, we examined whether PEG-IFN-alfa-2a monotherapy for 24 weeks or less...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Etoh, Reiko, Imazeki, Fumio, Kurihara, Tomoko, Fukai, Kenichi, Fujiwara, Keiichi, Arai, Makoto, Kanda, Tatsuo, Mikata, Rintaro, Yonemitsu, Yutaka, Yokosuka, Osamu
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3224591/
https://ncbi.nlm.nih.gov/pubmed/21884572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-4-316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados